Publication Cover
Anxiety, Stress, & Coping
An International Journal
Volume 27, 2014 - Issue 6
461
Views
14
CrossRef citations to date
0
Altmetric
BRIEF REPORT

Evidence for a curvilinear dose-response relationship between avoidance coping and drug use problems among women who experience intimate partner violence

, &
Pages 722-732 | Received 18 Nov 2013, Accepted 26 Feb 2014, Published online: 26 Mar 2014
 

Abstract

Women who experience intimate partner violence (IPV) are at heightened risk for drug use problems. While prevailing models of drug use suggest that IPV-exposed women use drugs in an effort to escape or avoid negative affect, a dearth of literature has examined the role of avoidance coping in drug use problems within this population. Given recent suggestions that flexible, situationally appropriate use of avoidance coping may be adaptive, particularly when confronted with highly stressful situations, we hypothesized that avoidance coping and drug use problems would demonstrate a curvilinear, U-shaped dose-response relationship. Participants were 147 community-recruited women experiencing IPV. Consistent with our hypotheses, moderate levels of avoidance coping were associated with lower levels of drug use problems, whereas high and low levels of avoidance coping were associated with higher levels of drug use problems. Findings highlight the complex relationship between avoidance coping and drug use problems and suggest that avoidance coping, when used in moderation, may be an adaptive strategy for coping with relational conflict among women who experience IPV.

Funding

This work was supported by the National Institutes of Health under Grant [grant number K23 DA019561], the National Institutes of Health under Grant [grant number T32DA019426], and the University of Connecticut General Clinical Research Center under Grant [grant number M01 RR06192].

Additional information

Funding

Funding: This work was supported by the National Institutes of Health under Grant [grant number K23 DA019561], the National Institutes of Health under Grant [grant number T32DA019426], and the University of Connecticut General Clinical Research Center under Grant [grant number M01 RR06192].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.